Anti-counterfeiting playbook for small- and mid-sized pharma companies

Learn how to implement risk-based anti-counterfeiting strategies that are critical to the success of a product launch

Add bookmark
woman-putting-medicine-into-white-jar

While larger pharma companies generally have anti-counterfeiting programs in place for risk management measures, small- and mid-sized pharma companies often overlook the critical need to implement product security measures early due to having limited management bandwidth.

For quick and easy strategy advice to overcome counterfeit risk when developing pharmaceutical products, download Authentix’s short guidebook.

Come away with lessons in how to:

  • Implement an advanced anti-counterfeiting program (ACP) for newly launched products.
  • Reduce significant risk in the pharma supply chain by following an ACP roadmap.
  • Five key steps for implementing an effective ACP program.

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended